Antidiabetics

Empagliflozin

Empagliflozin

What is Empagliflozin?

Empagliflozin is a sodium-glucose co-transporter-2 (SGLT2) inhibitor that lowers blood glucose by promoting its excretion in the urine. It also offers cardiovascular and renal protection, making it a preferred agent in patients with type 2 diabetes and coexisting heart or kidney conditions.

Uses of Empagliflozin :-

  • Type 2 diabetes management
  • Cardiovascular risk reduction
  • Chronic kidney disease benefit

Common Side Effects :-

  • Increased urination
  • Urinary tract infections
  • Thirst

Precautions & Warnings :-

  • Risk of genital infections.
  • Monitor kidney function regularly.
  • Not recommended in type 1 diabetes or severe renal impairment.
Scroll